Background: Treatment-resistant psychiatric disorders involving rigid maladaptive belief systems, including paranoid schizophrenia and delusional disorder, remain a persistent clinical challenge. Two structural barriers underlie the treatment gap: consolidated memories encoding maladaptive beliefs cannot be permanently erased, only reconsolidated, and paranoid presentations render logic-based therapeutic alliance structurally inaccessible, as therapeutic input is assimilated into the persecutory schema rather than processed as corrective evidence.

Objective: This paper introduces the Trust-Mediated Belief Access (TMBA) framework integrated with the Persona-Aligned Narrative Interface (PANI) — a multimodal AI architecture within the Belief Medicine™ paradigm. PANI operationalizes the trust pathway without identity impersonation. Rather than synthesizing agents modeled on specific individuals, PANI generates emotionally congruent communication styles aligned with the patient’s established trust archetypes, maintaining full AI transparency while engaging the attachment circuitry that enables access to the belief reconsolidation window.

Methods: A five-layer system architecture was proposed, integrating emotion sensing, cognitive belief encoding, PANI-based persona synthesis, adaptive narrative generation, and emotional delta feedback. A four-phase clinical protocol — Trust Profiling, PANI Synthesis, Adaptive Narrative Delivery, and Belief Reconsolidation Tracking — is specified, with contraindications, failure mode analysis, and a pilot study protocol (N=20, 8 weeks).

Results: Theoretical analysis grounded in memory reconsolidation neuroscience, attachment theory, and narrative therapy literature indicates that PANI-mediated trust-pathway delivery may access belief formation systems that are inaccessible to logic-based interventions. All efficacy projections are theoretical, and controlled clinical validation is the next mandatory step.

Conclusion: TMBA+PANI represents the most ethically conservative and theoretically grounded formulation of Belief Medicine™ to date, eliminating identity impersonation risk while preserving the mechanistic advantage of trust-pathway access. The Ethical Belief Rewriting Protocol (EBRP) governs the implementation of the program.

Keywords: Belief Medicine, PANI, Trust-Mediated Belief Access, Memory Reconsolidation, Multimodal AI, Computational Psychiatry, Maladaptive Beliefs, BeliefRecode AI, Narrative Therapy, Treatment-Resistant Psychosis

Velayutham S is an independent researcher and technologist from Chennai, India, working at the intersection of AI and cognitive psychology. He is the Founder of Belief Recode AI Pvt. Ltd. and the inventor of Belief Recode AI™ — an Emotion-Adaptive Belief Rewriting Engine for Cognitive Therapeutic Applications, filed with the Indian Patent Office. A speaker at the 3rd International Conference on Neurology & Neurological Disorders, London (2025), he has published in computational psychiatry and presents across the Belief Medicine™ paradigm. He also founded Loopback Cinema™ Technologies, merging art and AI for immersive storytelling.